Logo of Huzzle
Logo of Adaptimmune

Adaptimmune

Designing and delivering cell therapies to transform the lives of people with cancer.

Abingdon, Oxfordshire

•Website

👩‍💼

201-500

Employees

🗓

2008

Founded year

🏭

Technology

Industry

Mission & purpose

Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer. Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these therapies to harness the body's own immune system to find and destroy diseased cells. Our SPEAR TCR therapies offer promise to patients that often have no other options. We are working hard to make that promise a reality.